New science could turn some health systems into 'dinosaurs'.
Dr. Patrick Soon-Shiong is the founder and CEO of Culver City, Calif.-based NantHealth, which seeks to use big data to deliver personalized medicine. Last week, Allscripts Healthcare Solutions disclosed that it would pay $200 million for a 10% stake in NantHealth; Soon-Shiong said he plans a public stock offering by year-end. Soon-Shiong, who invented the blockbuster cancer drug Abraxane, founded drug companies Abraxis and American Pharmaceutical Partners, which he sold for a combined $9.1 billion. He also has served as global director of cancer services and bioinformatics at Providence Health & Services. Modern Healthcare reporter Beth Kutscher recently spoke with Soon-Shiong about how NantHealth will work with researchers, clinicians and payers to transform healthcare. This is an edited transcript.